META-ANALYSIS OF THE VALIDITY OF PROGRESSION-FREE SURVIVAL AS A SURROGATE ENDPOINT FOR OVERALL SURVIVAL IN METASTATIC COLORECTAL CANCER TRIALS

被引：0
|
作者：
Chirila, C. [1 ]
Odom, D. M. [1 ]
Devercelli, G. [2 ]
Khan, S. [3 ]
Sherif, B. N. [1 ]
Kaye, J. A. [4 ]
Molnar, I. [5 ]
Sherrill, B. H. [1 ]
机构：
[1] RTI Hlth Solut, Biometr, Res Triangle Pk, NC USA
[2] Bayer HealthCare, Global Hlth Econ & Outcomes Reasearch, Montville, NJ USA
[3] RTI Hlth Solut, Regular & Hlth Outcomes, Res Triangle Pk, NC USA
[4] RTI Hlth Solut, Epidemiol, Res Triangle Pk, NC USA
[5] Bayer HealthCare, Global Med Affairs, Montville, NJ USA
来源：
ANNALS OF ONCOLOGY | 2010年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：202 / 202
页数：1
相关论文
共 50 条
  • [1] Progression-free survival as a surrogate endpoint for overall survival in modern ovarian cancer trials: a meta-analysis
    Sjoquist, Katrin M.
    Lord, Sarah J.
    Friedlander, Michael L.
    Simes, Robert John
    Marschner, Ian C.
    Lee, Chee Khoon
    [J]. THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2018, 10 : 1 - 16
  • [2] Progression-free survival as a surrogate endpoint of overall survival in patients with metastatic colorectal cancer
    Cicero, Giuseppe
    De Luca, Rossella
    Dieli, Francesco
    [J]. ONCOTARGETS AND THERAPY, 2018, 11 : 3059 - 3063
  • [3] Interpretation of meta-analysis evaluating progression-free survival as a surrogate endpoint for overall survival in glioblastoma
    Han, Kelong
    Ren, Melanie
    Wick, Wolfgang
    Abrey, Lauren
    Das, Asha
    Jin, Jin
    Reardon, David A.
    [J]. NEURO-ONCOLOGY, 2015, 17 (05) : 764 - 765
  • [4] Meta-analysis of the association between progression-free survival and overall survival in metastatic colorectal cancer
    Chirila, Costel
    Odom, Dawn
    Devercelli, Giovanna
    Khan, Shahnaz
    Sherif, Bintu N.
    Kaye, James A.
    Molnar, Istvan
    Sherrill, Beth
    [J]. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2012, 27 (05) : 623 - 634
  • [5] Meta-analysis of the association between progression-free survival and overall survival in metastatic colorectal cancer
    Costel Chirila
    Dawn Odom
    Giovanna Devercelli
    Shahnaz Khan
    Bintu N. Sherif
    James A. Kaye
    István Molnár
    Beth Sherrill
    [J]. International Journal of Colorectal Disease, 2012, 27 : 623 - 634
  • [6] Progression-Free Survival as a Surrogate for Overall Survival in Advanced/Recurrent Gastric Cancer Trials: A Meta-Analysis
    Paoletti, Xavier
    Oba, Koji
    Bang, Yung-Jue
    Bleiberg, Harry
    Boku, Narikazu
    Bouche, Olivier
    Catalano, Paul
    Fuse, Nozomu
    Michiels, Stefan
    Moehler, Markus
    Morita, Satoshi
    Ohashi, Yasuo
    Ohtsu, Atsushi
    Roth, Arnaud
    Rougier, Philippe
    Sakamoto, Junichi
    Sargent, Daniel
    Sasako, Mitsuru
    Shitara, Kohei
    Thuss-Patience, Peter
    Van Cutsem, Eric
    Burzykowski, Tomasz
    Buyse, Marc
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2013, 105 (21) : 1667 - 1670
  • [7] A meta-analysis of randomized, controlled trials in metastatic melanoma establishes progression-free survival as a surrogate for overall survival
    Flaherty, K. T.
    Lee, S. J.
    Dummer, R.
    Hauschild, A.
    Hennig, M.
    Long, G. V.
    Lorigan, P.
    Robert, C.
    Schadendorf, D.
    [J]. EUROPEAN JOURNAL OF CANCER, 2013, 49 : S856 - S856
  • [8] EVALUATION OF PROGRESSION-FREE SURVIVAL AS A SURROGATE ENDPOINT FOR OVERALL SURVIVAL IN METASTATIC BREAST CANCER: SYSTEMATIC REVIEW AND TRIAL LEVEL META-ANALYSIS
    Adunlin, G.
    Dranitsaris, G.
    [J]. VALUE IN HEALTH, 2016, 19 (03) : A170 - A170
  • [9] Evaluation of Progression-Free Survival as a Surrogate Endpoint for Survival in Chemotherapy and Targeted Agent Metastatic Colorectal Cancer Trials
    Sidhu, Roger
    Rong, Alan
    Dahlberg, Steve
    [J]. CLINICAL CANCER RESEARCH, 2013, 19 (05) : 969 - 976
  • [10] Progression-free survival as a surrogate endpoint for overall survival in glioblastoma: a literature-based meta-analysis from 91 trials
    Han, Kelong
    Ren, Melanie
    Wick, Wolfgang
    Abrey, Lauren
    Das, Asha
    Jin, Jin
    Reardon, David A.
    [J]. NEURO-ONCOLOGY, 2014, 16 (05) : 696 - 706
12345